GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Research & Development

Hard to Treat Diseases (Hard to Treat Diseases) Research & Development : $ Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hard to Treat Diseases's Research & Development for the three months ended in . 20 was $0.00 Mil. Hard to Treat Diseases does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Hard to Treat Diseases Research & Development Historical Data

The historical data trend for Hard to Treat Diseases's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Research & Development Chart

Hard to Treat Diseases Annual Data
Trend
Research & Development

Hard to Treat Diseases Quarterly Data
Research & Development

Hard to Treat Diseases Research & Development Calculation

This is the expense the company spent on research and development.


Hard to Treat Diseases  (OTCPK:HTDS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hard to Treat Diseases Research & Development Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines